{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 6,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 9,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "AbbVie Submits New Drug Application in Japan for its Investigational, All-Oral, Treatment for Chronic",
            "Correlation": 10,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 7,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Unusual Options Activity: Calls: ABBV, EXPE, MO, CLR, Z, MA, ALK, ABBV, SIRI, CVX, ZIOP, DDD, UNIS, COP, FEYE, TRIP",
            "Correlation": 6,
            "Sentiment": 4,
            "Importance": 5,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 6,
            "Sector_Spread": 10,
            "Tech_Mentions": 4
        }
    ]
}